行氣化瘀針法治療瘀血阻絡型偏頭痛的臨床研究

《行氣化瘀針法治療瘀血阻絡型偏頭痛的臨床研究》由會員上傳分享，免費在線閱讀，更多相關(guān)內(nèi)容在學術(shù)論文-天天文庫。

1、學校代號10199學號：20125124039碩士學位論文碩士學位論文行氣化瘀針法治療瘀血阻絡型偏頭痛的臨床研究Clinicalstudyofxingqihuayuacupunctureintreatingbloodstasistypeofmigraine學位申請人王紅導師姓名職稱洪杰教授專業(yè)名稱針灸推拿學研究方向特定穴理論與臨床研究培養(yǎng)方式全日制申請學位類型專業(yè)學位論文提交日期2015年4月分類號密級ＵＤＣ編號碩±學位論文行命化癡針法治療療血祖絡型偏頭痛的臨床研究Ｃｌｉｎｉｃａ

2、ｌｓｔｕｄｏｆｘｉｎｉｈｕａｕｙｇｑｙａｃｕｐｕｎｃｔｕｒｅｉｎｔｒｅａｔｉｎｂｌｏｏｄｓｔａｓｉｓｔｅｏｆｇｙｐｍｉｒａｉｎｅｇ王結(jié)指導教師姓名：洪杰教授（長春中醫(yī)藥大學）申請學位級別：碩±專業(yè)名稱：針灸推拿學論文提交日期：２０１５年４月論文答辯日期：２０１５年６月學位授予單位：長春中醫(yī)藥大學提交確認：作者簽名疏導師簽名：＿＿長春中醫(yī)藥大學學位論文原創(chuàng)性聲明本人鄭重聲明：所呈交的學位論文，是個人在導師的指導下，獨立進行研究工作所取得的成

3、果Ｃ除文中已經(jīng)特別加ａ注明引用的內(nèi)容外，本論文不含任何其他個人或集體已經(jīng)發(fā)表或撰寫過的己在文中Ｗ明確方式標明并致謝。本人完作品成果。對本文的祝究做出重要貢獻的個人和集體，均全意識到本聲明的法律結(jié)果由本人承擔。學位論文作者簽名＿２＾１丈年＾月／口曰關(guān)于學位論文成果歸屬權(quán)的聲明本人鄭重聲明：所呈交的學位論文，是本人在導師指導下自選課題或?qū)煶袚膰伊㈨椯Y助的計劃課題的一部分，系本人在導師指導和資助下獨立進行研究工作所取得的成果，歸屬權(quán)為長春一中醫(yī)藥大學和本人導師所有。特此再明，論本聲文

4、明的切法律責任由本人承擔。作者簽名＿王化指導教么師簽名？／１啤谷月關(guān)于學位論文使用授權(quán)的聲明本人完全了解長春中醫(yī)藥大學有關(guān)保留使用學位論文的規(guī)定，同意學校保留并向中國科學技術(shù)信息研究所及中國學術(shù)期刊（光盤版）電子雜志社送交論文的復印件和電子版，允許被查閱和借閱。本人授權(quán)長春中醫(yī)藥大學可Ｕ將本學位論文的全部或部分內(nèi)容編人《中國學位論文全文數(shù)據(jù)庫》及《中國優(yōu)秀博碩±學位論文全文數(shù)據(jù)庫》進行檢索，可＾心采用影印、縮印或其他復印手段保存和匯編本學位論文。（保密論文在解密后應遵守此規(guī)定

5、）論文作者簽名＿＿指導教師簽名年月Ｚｏｉｒ６長春中醫(yī)藥大學2015屆碩士學位論文目錄目錄中文摘要·································································································1英文摘要·································································································2英文

6、縮略語······························································································4前言·································································································5文獻綜述··························································

7、·······································61偏頭痛的中醫(yī)學研究進展·······································································62偏頭痛的現(xiàn)代醫(yī)學研究進展····································································11臨床研究·················································

8、················································181病例選擇·····························································································182診斷標準·························